538 related articles for article (PubMed ID: 18045646)
1. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST
Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646
[TBL] [Abstract][Full Text] [Related]
2. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
[TBL] [Abstract][Full Text] [Related]
3. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
[TBL] [Abstract][Full Text] [Related]
4. HER2 and EGFR expression in cutaneous spindle squamous cell carcinoma.
Schlauder SM; Calder KB; Moody P; Morgan MB
Am J Dermatopathol; 2007 Dec; 29(6):559-63. PubMed ID: 18032952
[TBL] [Abstract][Full Text] [Related]
5. Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck.
Do NY; Lim SC; Im TS
Oncol Rep; 2004 Aug; 12(2):229-37. PubMed ID: 15254682
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.
Grandis JR; Tweardy DJ
Cancer Res; 1993 Aug; 53(15):3579-84. PubMed ID: 8339264
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of an activation state marker for epidermal growth factor receptor in tissue microarrays of head and neck cancer.
Kong A; Leboucher P; Leek R; Calleja V; Winter S; Harris A; Parker PJ; Larijani B
Cancer Res; 2006 Mar; 66(5):2834-43. PubMed ID: 16510606
[TBL] [Abstract][Full Text] [Related]
9. Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma.
Sheikh Ali MA; Gunduz M; Nagatsuka H; Gunduz E; Cengiz B; Fukushima K; Beder LB; Demircan K; Fujii M; Yamanaka N; Shimizu K; Grenman R; Nagai N
Cancer Sci; 2008 Aug; 99(8):1589-94. PubMed ID: 18754871
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder.
Wang X; Zhang S; MacLennan GT; Eble JN; Lopez-Beltran A; Yang XJ; Pan CX; Zhou H; Montironi R; Cheng L
Clin Cancer Res; 2007 Feb; 13(3):953-7. PubMed ID: 17289890
[TBL] [Abstract][Full Text] [Related]
11. Decreased survival in EGFR gene amplified vulvar carcinoma.
Growdon WB; Boisvert SL; Akhavanfard S; Oliva E; Dias-Santagata DC; Kojiro S; Horowitz NS; Iafrate AJ; Borger DR; Rueda BR
Gynecol Oncol; 2008 Nov; 111(2):289-97. PubMed ID: 18768215
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial.
Bentzen SM; Atasoy BM; Daley FM; Dische S; Richman PI; Saunders MI; Trott KR; Wilson GD
J Clin Oncol; 2005 Aug; 23(24):5560-7. PubMed ID: 16110017
[TBL] [Abstract][Full Text] [Related]
13. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
Ang KK; Berkey BA; Tu X; Zhang HZ; Katz R; Hammond EH; Fu KK; Milas L
Cancer Res; 2002 Dec; 62(24):7350-6. PubMed ID: 12499279
[TBL] [Abstract][Full Text] [Related]
14. Are epidermal growth factor and transforming growth factor responsible for pseudoepitheliomatous hyperplasia associated with granular cell tumors?
Barkan GA; Paulino AF
Ann Diagn Pathol; 2003 Apr; 7(2):73-7. PubMed ID: 12715330
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of primary site biopsies in head and neck squamous cell carcinoma.
Moertel S; Ackermann H; Baghi M; Eckardt A; Wagenblast J; Stöver T; Hambek M
Anticancer Res; 2011 Feb; 31(2):665-9. PubMed ID: 21378353
[TBL] [Abstract][Full Text] [Related]
16. Skp2, p27kip1 and EGFR assessment in head and neck squamous cell carcinoma: prognostic implications.
Carracedo DG; Astudillo A; Rodrigo JP; Suarez C; Gonzalez MV
Oncol Rep; 2008 Sep; 20(3):589-95. PubMed ID: 18695910
[TBL] [Abstract][Full Text] [Related]
17. Characterization of ten newly-derived human head and neck squamous carcinoma cell lines with special reference to c-erbB proto-oncogene expression.
O-Charoenrat P; Rhys-Evans P; Eccles S
Anticancer Res; 2001; 21(3B):1953-63. PubMed ID: 11497283
[TBL] [Abstract][Full Text] [Related]
18. Metastatic cutaneous squamous cell carcinoma to the parotid and cervical lymph nodes: treatment and outcomes.
Bumpous J
Curr Opin Otolaryngol Head Neck Surg; 2009 Apr; 17(2):122-5. PubMed ID: 19346945
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis.
Shin DM; Ro JY; Hong WK; Hittelman WN
Cancer Res; 1994 Jun; 54(12):3153-9. PubMed ID: 8205534
[TBL] [Abstract][Full Text] [Related]
20. LOXL4 as a selective molecular marker in primary and metastatic head/neck carcinoma.
Scola N; Görögh T
Anticancer Res; 2010 Nov; 30(11):4567-71. PubMed ID: 21115907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
